A detailed history of Handelsbanken Fonder Ab transactions in Moderna, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 120,273 shares of MRNA stock, worth $4.74 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
120,273
Previous 118,833 1.21%
Holding current value
$4.74 Million
Previous $14.1 Million 43.04%
% of portfolio
0.03%
Previous 0.06%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$63.64 - $125.14 $91,641 - $180,201
1,440 Added 1.21%
120,273 $8.04 Million
Q2 2024

Aug 05, 2024

SELL
$101.21 - $166.61 $747,739 - $1.23 Million
-7,388 Reduced 5.85%
118,833 $14.1 Million
Q1 2024

May 13, 2024

BUY
$85.37 - $115.44 $887,250 - $1.2 Million
10,393 Added 8.97%
126,221 $13.5 Million
Q4 2023

Feb 01, 2024

SELL
$69.51 - $104.43 $6.2 Million - $9.31 Million
-89,169 Reduced 43.5%
115,828 $11.5 Million
Q3 2023

Oct 19, 2023

BUY
$96.41 - $126.61 $504,513 - $662,550
5,233 Added 2.62%
204,997 $21.2 Million
Q2 2023

Aug 02, 2023

SELL
$118.5 - $160.53 $4.05 Million - $5.49 Million
-34,192 Reduced 14.61%
199,764 $24.3 Million
Q1 2023

Apr 28, 2023

SELL
$135.66 - $197.02 $223,567 - $324,688
-1,648 Reduced 0.7%
233,956 $35.9 Million
Q4 2022

Feb 07, 2023

BUY
$118.38 - $210.04 $2.23 Million - $3.96 Million
18,854 Added 8.7%
235,604 $42.3 Million
Q3 2022

Oct 27, 2022

SELL
$118.07 - $194.18 $922,598 - $1.52 Million
-7,814 Reduced 3.48%
216,750 $25.6 Million
Q2 2022

Aug 03, 2022

BUY
$117.13 - $176.59 $1.2 Million - $1.81 Million
10,242 Added 4.78%
224,564 $32.1 Million
Q1 2022

May 11, 2022

BUY
$126.46 - $235.05 $9.39 Million - $17.4 Million
74,221 Added 52.98%
214,322 $36.9 Million
Q4 2021

Feb 08, 2022

BUY
$225.82 - $368.51 $3.07 Million - $5.02 Million
13,613 Added 10.76%
140,101 $35.6 Million
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $2.77 Million - $6.05 Million
12,490 Added 10.96%
126,488 $48.7 Million
Q2 2021

Aug 03, 2021

SELL
$129.91 - $234.98 $4.15 Million - $7.5 Million
-31,936 Reduced 21.88%
113,998 $26.8 Million
Q1 2021

Apr 29, 2021

BUY
$109.18 - $185.98 $2.16 Million - $3.67 Million
19,759 Added 15.66%
145,934 $19.1 Million
Q4 2020

Feb 11, 2021

BUY
$65.74 - $169.86 $4.92 Million - $12.7 Million
74,870 Added 145.93%
126,175 $13.2 Million
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $864,006 - $1.51 Million
15,900 Added 44.91%
51,305 $3.63 Million
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $1.05 Million - $2.83 Million
35,405 New
35,405 $2.27 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.